Table 1.

Patient details. In this table, the patient details of the two groups are presented (AG: Adenomyosis Group, histologically confirmed adenomyosis; CG: Control Group, no histological evidence of adenomyosis). The patients are numbered within each group. Age at MRI is provided (in years). G/P (Gravida/Para). The endocrine therapy as follows in the table (0: none, 1: COC (combined oral contraceptive), 2: Gestagen (Dienogest), 3: Levonorgestrel-IUD, 4: GnRH-Analogue). In the context of endocrine therapy and duration, therapies taken prior to the MRI are referred to. Additionally, preoperative TVUS based on MUSA criteria, conventional MRI, and intraoperative endometriosis findings based on #Enzian (s) are shown.

Patients	Age	G/P	Endocrine Therapy	Endocrine Therapy Duration before MRI (Months)	Adenomyosis in TVUS	Adenomyosis in Conventional MRI	Duration MRI—Surgery (Months)	Endometriosis (Intraoperative #Enzian)
AG
1	33	0/0	2	1	No	Yes	4	P2, T3/3, A2, B2/1, C1, FA
2	42	0/0	1	36	Yes	Yes	5	P1, FA
3	44	II/I	0	0	Yes	Yes	3	P1, O1/1, T1/1, A3, B2/1, FA, FB
4	35	I/I	2	2	Yes	No	1	P2, O1/1, T1,1, A2, FA, FB
5	47	II/II	3	3	Yes	Yes	1	P2, O2/2, T3/3, A2, B1/1, C1, FA, FB
6	42	0/0	4	2	Yes	Yes	5	P2, O1/0, T3/1, B1/0, FA
7	41	I/I	0	0	Yes	Yes	2	P2, O1/1, T1/1, A3, B1/1, C3, FA, FB
8	39	0/0	0	0	Yes	Yes	1	P3, T2/0, A3, B2/1, C1, FA, FU
9	44	III/II	2	2	Yes	Yes	1	P3, O3/3, T3/3, A3, B3/3, C2, FA, FU, FI (Sigma)
CG
1	38	II/I	0	0	No	No	2	P1, O1/1, T0/1, B1/1, FB
2	48	I/I	2	1	No	Yes	1	P2, O2/0, B1/1
3	37	IV/III	2	3	No	Yes	1	P1, O2/1, T1/1, A1
4	40	II/II	3	5	No	No	2	P1, O1/2, T1/1, A2, B1/0, C1
5	39	II/II	0	0	Yes	Yes	4	FB
6	40	0/0	0	0	No	Yes	2	FO (umbilicus)